T A Ban - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

T A Ban

Showing results (191-200 of 257) with videos related to

Pageof 26

Sort By:

Internationale Zeitschrift Fur Klinische Pharmakologie, Therapie, Und Toxikologie. International Journal of Clinical Pharmacology, Therapy, and Toxicology|February 1, 1971

Fluphenazine enanthate in the treatment of chronic psychotic patients: a controlled clinical studyR Deverteuil, H E Lehmann, T A Ban, et al.

Psychopharmacology Bulletin|January 1, 1995

International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: III. Clinical features affecting experts' therapeutic recommendations in anxiety disordersE H Uhlenhuth, M B Balter, T A Ban, et al.

Canadian Psychiatric Association Journal|February 1, 1970

Nicotinic acid in the prevention and treatment of methionine-induced exacerbation of psychopathology in schizophrenicsJ V Ananth, T A Ban, H E Lehmann, et al.

Current Therapeutic Research, Clinical and Experimental|April 1, 1970

CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patientsC Villeneuve, J V Ananth, T A Ban, et al.

Canadian Psychiatric Association Journal|April 1, 1972

Propericiazine in psychiatric emergencies. A controlled comparative studyJ V Ananth, M Salib, T A Ban, et al.

Psychopharmacology Bulletin|January 1, 1978

Doxepin and imipramine in the treatment of depression: a double-blind crossover clinical study with EKG recordingsM M Amin, T A Ban, H E Lehmann, et al.

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 6, 2000

Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992-1997E H Uhlenhuth, M B Balter, T A Ban, et al.

Laval Medical|September 1, 1970

Effect of withdrawal of antiparkinsonian medication on chronically hospitalized psychiatric patientsJ V Ananth, S Horodesky, H E Lehmann, et al.

The Journal of Clinical Psychiatry|August 1, 1981

Amoxapine: once versus divided daily doses in neurotic and endogenous depressionM Ragheb, W H Wilson, T A Ban, et al.

Psychopharmacology Bulletin|January 1, 1978

R--806--03--01 in the treatment of depression: plasma levels and therapeutic responseM M Amin, T A Ban, H E Lehmann, et al.

Pageof 26

Search research articles

Showing results (191-200 of 257) with videos related to

Sort By:

Pageof 26

Internationale Zeitschrift Fur Klinische Pharmakologie, Therapie, Und Toxikologie. International Journal of Clinical Pharmacology, Therapy, and Toxicology|February 1, 1971

Fluphenazine enanthate in the treatment of chronic psychotic patients: a controlled clinical studyR Deverteuil, H E Lehmann, T A Ban, et al.

Psychopharmacology Bulletin|January 1, 1995

Canadian Psychiatric Association Journal|February 1, 1970

Nicotinic acid in the prevention and treatment of methionine-induced exacerbation of psychopathology in schizophrenicsJ V Ananth, T A Ban, H E Lehmann, et al.

Current Therapeutic Research, Clinical and Experimental|April 1, 1970

CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patientsC Villeneuve, J V Ananth, T A Ban, et al.

Canadian Psychiatric Association Journal|April 1, 1972

Propericiazine in psychiatric emergencies. A controlled comparative studyJ V Ananth, M Salib, T A Ban, et al.

Psychopharmacology Bulletin|January 1, 1978

Doxepin and imipramine in the treatment of depression: a double-blind crossover clinical study with EKG recordingsM M Amin, T A Ban, H E Lehmann, et al.

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 6, 2000

Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992-1997E H Uhlenhuth, M B Balter, T A Ban, et al.